V. The stigma of anxiety disorders

International Journal of Clinical Practice

Volumn 54, Issue 1, 2000, Pages 44-47

  Davies, Mark R B ^a,b  

^a Locality Mental Health Team ^*  (United Kingdom)

^b Waterford House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ANXIETY NEUROSIS; COGNITIVE THERAPY; DIAGNOSTIC ERROR; DRUG DEPENDENCE; HUMAN; PERSONALITY DISORDER; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PSYCHOTHERAPY; SHORT SURVEY; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; HEALTH PERSONNEL ATTITUDE; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY;

ANXIETY DISORDERS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; HUMANS; STEREOTYPING;

EID: 0033624929     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Sartorius N. Stigma: what can psychiatrists do about it? Lancet 1998; 352: 1058-1059.
2. Kessler RC, Mcgonagle KA, Zhoo S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8-19.
3. Ustun TB, Sartorius N. Mental health in general health care. Chichester: Wiley, 1995.
4. Cowan L, Hart D. (1988) Changing minds: every family in the land. Psychiatr Bull 1988; 22: 593-554.
5. Regier DA, Kaelber CT, Rae DS et al. Limitations of diagnostic criteria and assessment instruments for mental disorders. Arch Gen Psychiatry 1998; 55: 109-115
6. Rice D P, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998; 173(suppl): 4-9.
7. Gelder M, Gath D, Mayou R, Cowen P. Oxford textbook of psychiatry, 3rd edn. Oxford: Oxford University Press, 1996.
8. Regier DA, Rae DS, Narrow WE et al. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 173(suppl): 24-28.
9. Lader MH, Bond AJ. Interaction of pharmacological and psychological treatments of anxiety. Br J Psychiatry 1998; 173(suppl): 24-28.
10. Petursson H, Lader M. Dependence on tranquillizers, Maudsley Monograph no 28, Oxford: Oxford University Press, 1984.
11. Dubovsky SL. Generalised anxiety disorder: new concepts and psychopharmacologic therapies. J Clin Psychiatry 1990; 51(suppl): 3-10.
12. Nutt DJ. The pharmacology of anxiety. Br J Hosp Med 1996; 55: 187-191.
13. Swinson RP, Kuch K, Antony MM. Combining pharmacotherapy for panic disorder and agoraphobia. In: Panic disorder and agoraphobia. Belmont, California: Wadsworth 1991; 306-334.
14. Fineberg N, Drummond LM. Anxiety disorders: drug treatment or behavioural cognitive psychotherapy? CNS Drugs 1995; 3: 448-466.
15. Michelson LK, Marchione K.(1991) Behavioural, cognitive and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 1991; 59: 100-114.
16. Marks I, O'Sullivan G. Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review. Br J Psychiatry 1988; 153: 650-658.
17. Kemp R, Hayward P, Applewhaite G et al. (1996) Compliance therapy in psychotic patients: a randomized controlled trial. BMJ 1996; 312: 345-349.
18. Lakshman M, Fernando D, Kazarian SS. (1995) Patient education in the drug treatment of psychiatric disorders: effect on compliance and outcome. CNS Drugs 1995; 3: 291-304.